Hikma Pharmaceutical

London Exchange

Hikma appoints new President of Injectables business
ByNNR August 9, 2023October 24, 2023

LONDON, UK: Hikma Pharmaceuticals PLC and its subsidiaries announcd that Dr. Bill Larkins has been appointed President of its Injectables business, effective 1 September 2023. Bill will be based in the US and report to Riad Mishlawi in his new…

Read More Hikma appoints new President of Injectables business
London Exchange

Hikma Launches New 503B Sterile Compounding Business
ByNNR January 10, 2022October 24, 2023

LONDON, UK: Hikma Pharmaceuticals, the multinational pharmaceutical company, announced the launch of Hikma 503B – a new outsourced sterile compounding business focused on providing high quality, ready-to-administer injectable medications that are customized to the specific needs of patients in the…

Read More Hikma Launches New 503B Sterile Compounding Business